2/26
07:30 am
hbio
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
Low
Report
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
2/10
07:30 am
hbio
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
Medium
Report
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
1/29
07:04 pm
hbio
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth [Yahoo! Finance]
Medium
Report
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth [Yahoo! Finance]
1/29
04:30 pm
hbio
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
Medium
Report
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
12/17
07:30 am
hbio
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
High
Report
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
12/13
07:50 am
hbio
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Harvard Bioscience (NASDAQ:HBIO) was upgraded by analysts at Zacks Research to a "hold" rating.